What is infectiveness and how is it involved in infection and immunity?

BMC Immunology

Volumn 16, Issue 1, 2015, Pages

  Pirofski, Liise anne ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; POLYSACCHARIDE; VIRULENCE FACTOR; PATTERN RECOGNITION RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ANTIMICROBIAL THERAPY; BACTERIAL VIRULENCE; CHEMOTHERAPY; COMMENSALISM; CONCEPTUAL FRAMEWORK; CYTOTOXIC CHEMOTHERAPY; DAMAGE RESPONSE FRAMEWORK; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNITY; INFECTION; INFECTIVENESS; INNATE IMMUNITY; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; MICROORGANISM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; REVIEW; SURGERY; ANIMAL; HISTORY; IMMUNOLOGY; MICROBIOLOGY; TRANSMISSION; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNITY; INFECTION; MICROBIOLOGY; RECEPTORS, PATTERN RECOGNITION; VIRULENCE;

EID: 84925395779     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/s12865-015-0076-1     Document Type: Review

References (31)

1. Casadevall A, Scharff MD. Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis. 1995;21(1):150-61.
2. Casadevall A, Pirofski L. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun. 1999;67:3703-13.
3. Casadevall A, Pirofski L. Host-pathogen interactions. II. The basic concepts of microbial commensalism, colonization, infection and disease. Infect Immun. 2000;68:6511-8.
4. Casadevall A, Pirofski L. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol. 2003;1:17-24.
5. Casadevall A, Pirofski L. Host-pathogen interactions: the attributes of virulence. J Infect Dis. 2001;184:337-45.
6. Casadevall A, Pirofski L. What is a host? Incorporating the microbiota into the damage-response framework. Infect Immun. 2014.In press.
7. Linden PK. History of solid organ transplantation and organ donation. Crit Care Clin. 2009;25(1):165-84. 1.
8. De Cock KM, Jaffe HW, Curran JW. Reflections on 30 years of AIDS. Emerg Infect Dis. 2011;17(6):1044-8.
9. Casadevall A. Crisis in infectious diseases: time for a new paradigm? Clin Infect Dis. 1996;23:790-4.
10. Harbarth S, Samore MH. Antimicrobial resistance determinants and future control. Emerg Infect Dis. 2005;11(6):794-801.
11. Pang T, Guindon GE. Globalization and risks to health. EMBO Rep. 2004;5 Spec No:S11-6.
12. Rappole JH, Derrickson SR, Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis. 2000;6(4):319-28.
13. Altizer S, Ostfeld RS, Johnson PT, Kutz S, Harvell CD. Climate change and infectious diseases: from evidence to a predictive framework. Science. 2013;341(6145):514-9.
14. Altizer S, Bartel R, Han BA. Animal migration and infectious disease risk. Science. 2011;331(6015):296-302.
15. Garcia-Solache MA, Casadevall A. Global warming will bring new fungal diseases for mammals. MBio. 2010;1(1).
16. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783-801.
17. Broz P, Monack DM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol. 2013;13(8):551-65.
18. Ting JP, Duncan JA, Lei Y. How the noninflammasome NLRs function in the innate immune system. Science. 2010;327(5963):286-90.
19. Netea MG, van de Veerdonk FL, van der Meer JW. Primary immunodeficiencies of pattern recognition receptors. J Intern Med. 2012;272(6):517-27.
20. Alcais A, Abel L, Casanova JL. Human genetics of infectious diseases: between proof of principle and paradigm. J Clin Invest. 2009;119(9):2506-14.
21. Picard C, Abel L, Casanova JL. Human monogenic disorders that confer predisposition to specific infections. Novartis Found Symp. 2007;281:65-73.
22. Bassiri H, Janice Yeo WC, Rothman J, Koretzky GA, Nichols KE. X-linked Lymphoproliferative Disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses. Immunol Res. 2008;42(1-3):145-59.
23. Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev. 2004;197:179-91.
24. Subramaniam K, Metzger B, Hanau LH, et al. IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status. J Infect Dis. 2009;200(2):244-51.
25. Shi Y, Yamazaki T, Okubo Y, Uehara Y, Sugane K, Agematsu K. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol. 2005;175(5):3262-7.
26. Agematsu K, Futatani T, Hokibara S, et al. Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol. 2002;103(1):34-42.
27. Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med. 2003;197(7):939-45.
28. Bernasconi NL, Taggiani E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2003;298:2199-202.
29. Capolunghi F, Rosado MM, Sinibaldi M, Aranburu A, Carsetti R. Why do we need IgM memory B cells? Immunol Lett. 2013;152(2):114-20.
30. Lanzavecchia A, Sallusto F. Human B cell memory. Curr Opin Immunol. 2009;21(3):298-304.
31. Casadevall A, Fang FC, Pirofski LA. Microbial virulence as an emergent property: consequences and opportunities. PLoS Pathog. 2011;7(7):e1002136.